Literature DB >> 12106881

Immunoregulatory molecules during pregnancy and at birth.

Lynsey L Power1, Eleanor J Popplewell, Judith A Holloway, Norma D Diaper, John O Warner, Catherine A Jones.   

Abstract

Regulation of the maternal immune response to the fetal allograft is essential for the success of pregnancy and delivery of a well-developed neonate. Numerous mechanisms have been postulated to mediate this. We hypothesised that the potent immunosuppressive molecules TGF-beta1 and IL-10 could contribute to this regulation in the mother and neonate during gestation. In comparison to non-pregnant women, TGF-beta1 and cortisol levels were increased significantly in mid (16-18 weeks) and late pregnancy (>37 weeks, no labour), with levels of both highest in late gestation. In contrast, IL-10 levels were significantly lower in maternal plasma in mid-gestation compared with that from late pregnancy and from non-pregnant women. TGF-beta1, IL-10 and cortisol were all detectable in umbilical cord blood plasma with TGF-beta1 levels significantly decreased in association with labour in contrast to cortisol levels that increased with labour. IL-10 levels in cord plasma were comparable to those of adults and did not change with mode of delivery. Elevated levels of TGF-beta1, but not IL-10, in the maternal and neonatal circulation could have a role in immunoregulation of the maternal response to the fetal allograft as well as growth and development of the fetus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106881     DOI: 10.1016/s0165-0378(01)00146-2

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  9 in total

1.  The early life origins of asthma and related allergic disorders.

Authors:  J O Warner
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

2.  Incomplete activation of peripheral blood dendritic cells during healthy human pregnancy.

Authors:  S Della Bella; S Giannelli; V Cozzi; V Signorelli; M Cappelletti; I Cetin; M L Villa
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

3.  Expression of TGF-betal in placenta of the patients with pregnancy-induced hypertension and its relationship with serum VCAM-1.

Authors:  Wenpei Xiang; Xiaoyan Xu; Hanping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

4.  Transfer of maternal cytokines to suckling piglets: in vivo and in vitro models with implications for immunomodulation of neonatal immunity.

Authors:  Trang V Nguyen; Lijuan Yuan; Marli S P Azevedo; Kwang-Il Jeong; Ana-Maria Gonzalez; Linda J Saif
Journal:  Vet Immunol Immunopathol       Date:  2007-03-01       Impact factor: 2.046

5.  Characterization of the Highly Prevalent Regulatory CD24hiCD38hi B-Cell Population in Human Cord Blood.

Authors:  Ana Esteve-Solé; Irene Teixidó; Angela Deyà-Martínez; Jordi Yagüe; Ana M Plaza-Martín; Manel Juan; Laia Alsina
Journal:  Front Immunol       Date:  2017-03-07       Impact factor: 7.561

6.  Androgen-induced alterations in endometrial proteins crucial in recurrent miscarriages.

Authors:  Tanzil Ur Rahman; Kamran Ullah; Meng-Xi Guo; Hai-Tao Pan; Juan Liu; Jun Ren; Lu-Yang Jin; Yu-Zhong Zhou; Yi Cheng; Jian-Zhong Sheng; He-Feng Huang
Journal:  Oncotarget       Date:  2018-05-15

7.  Does Altered Cellular Metabolism Underpin the Normal Changes to the Maternal Immune System during Pregnancy?

Authors:  Benjamin J Jenkins; April Rees; Nicholas Jones; Catherine A Thornton
Journal:  Immunometabolism       Date:  2021-10-04

Review 8.  The Foetal Origins of Allergy and Potential Nutritional Interventions to Prevent Disease.

Authors:  John O Warner; Jill Amanda Warner
Journal:  Nutrients       Date:  2022-04-12       Impact factor: 6.706

9.  Effective prediction of preeclampsia by measuring serum angiotensin II, urinary angiotensinogen and urinary transforming growth factor β1.

Authors:  Lihong Zhang; Yunjiao Zhou; Qing Wu; Weifeng Fan; Jun Ye; Yaping Chen; Yun Wu; Jianying Niu; Yong Gu
Journal:  Exp Ther Med       Date:  2017-05-22       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.